83 related articles for article (PubMed ID: 24840555)
1. APOBEC3 signature mutations in chronic lymphocytic leukemia.
Rebhandl S; Huemer M; Gassner FJ; Zaborsky N; Hebenstreit D; Catakovic K; Grössinger EM; Greil R; Geisberger R
Leukemia; 2014 Sep; 28(9):1929-32. PubMed ID: 24840555
[No Abstract] [Full Text] [Related]
2. APOBEC3-mediated restriction of RNA virus replication.
Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
[TBL] [Abstract][Full Text] [Related]
3. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
Roelofs PA; Martens JWM; Harris RS; Span PN
Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
[TBL] [Abstract][Full Text] [Related]
4. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
Swanton C; McGranahan N; Starrett GJ; Harris RS
Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis.
Maciejowski J; Chatzipli A; Dananberg A; Chu K; Toufektchan E; Klimczak LJ; Gordenin DA; Campbell PJ; de Lange T
Nat Genet; 2020 Sep; 52(9):884-890. PubMed ID: 32719516
[TBL] [Abstract][Full Text] [Related]
6. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
[TBL] [Abstract][Full Text] [Related]
7. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
Petljak M; Green AM; Maciejowski J; Weitzman MD
Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3 enzymes restrict marginal zone B cells.
Beck-Engeser GB; Winkelmann R; Wheeler ML; Shansab M; Yu P; Wünsche S; Walchhütter A; Metzner M; Vettermann C; Eilat D; DeFranco A; Jäck HM; Wabl M
Eur J Immunol; 2015 Mar; 45(3):695-704. PubMed ID: 25501566
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide mutation avalanches induced in diploid yeast cells by a base analog or an APOBEC deaminase.
Lada AG; Stepchenkova EI; Waisertreiger IS; Noskov VN; Dhar A; Eudy JD; Boissy RJ; Hirano M; Rogozin IB; Pavlov YI
PLoS Genet; 2013; 9(9):e1003736. PubMed ID: 24039593
[TBL] [Abstract][Full Text] [Related]
10. Targeting APOBECs in cancer: It's about timing.
Hata AN; Larijani M
Cancer Cell; 2024 Apr; 42(4):497-501. PubMed ID: 38593778
[TBL] [Abstract][Full Text] [Related]
11. Discovery of cytosine deaminases enables base-resolution methylome mapping using a single enzyme.
Vaisvila R; Johnson SR; Yan B; Dai N; Bourkia BM; Chen M; Corrêa IR; Yigit E; Sun Z
Mol Cell; 2024 Mar; 84(5):854-866.e7. PubMed ID: 38402612
[TBL] [Abstract][Full Text] [Related]
12. The underexplored role of APOBEC3 enzymes in autoimmune diseases.
Liu YT; Meng XY
Rheumatology (Oxford); 2024 May; 63(6):e166-e167. PubMed ID: 38060252
[No Abstract] [Full Text] [Related]
13. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
Sutton LA; Rosenquist R
Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
[TBL] [Abstract][Full Text] [Related]
14. AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.
Huemer M; Rebhandl S; Zaborsky N; Gassner FJ; Hainzl S; Weiss L; Hebenstreit D; Greil R; Geisberger R
Eur J Immunol; 2014 Dec; 44(12):3747-57. PubMed ID: 25179679
[TBL] [Abstract][Full Text] [Related]
15. AID/APOBEC deaminases and cancer.
Rebhandl S; Huemer M; Greil R; Geisberger R
Oncoscience; 2015; 2(4):320-33. PubMed ID: 26097867
[TBL] [Abstract][Full Text] [Related]
16. IL-10 regulates Aicda expression through miR-155.
Fairfax KA; Gantier MP; Mackay F; Williams BR; McCoy CE
J Leukoc Biol; 2015 Jan; 97(1):71-8. PubMed ID: 25381386
[TBL] [Abstract][Full Text] [Related]
17. Active DNA demethylation-The epigenetic gatekeeper of development, immunity, and cancer.
Prasad R; Yen TJ; Bellacosa A
Adv Genet (Hoboken); 2021 Mar; 2(1):e10033. PubMed ID: 36618446
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes.
Wiecek AJ; Jacobson DH; Lason W; Secrier M
Front Cell Dev Biol; 2021; 9():698659. PubMed ID: 34307377
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator.
Takei H; Fukuda H; Pan G; Yamazaki H; Matsumoto T; Kazuma Y; Fujii M; Nakayama S; Kobayashi IS; Shindo K; Yamashita R; Shirakawa K; Takaori-Kondo A; Kobayashi SS
Int J Hematol; 2020 Sep; 112(3):395-408. PubMed ID: 32533515
[TBL] [Abstract][Full Text] [Related]
20. RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia.
Gassner FJ; Zaborsky N; Feldbacher D; Greil R; Geisberger R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
